Corporate Presentation: June 2024 - MarketScreener
NASDAQ: OTLK outlooktherapeutics.com Redefining the Standard of Carefor Ophthalmic Therapies Corporate...
Stay updated with breaking news from Complete Response Letter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NASDAQ: OTLK outlooktherapeutics.com Redefining the Standard of Carefor Ophthalmic Therapies Corporate...
NEW YORK, May 26, 2024 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims…
NEW YORK, May 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Verrica Pharmaceuticals, Inc. (NASDAQ: VRCA)
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN)....
Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK and SOUTH SAN FRANCISCO,...